Product Code: GVR-2-68038-893-0
Ambulatory Surgery Centers Market Summary
The global ambulatory surgery centers market size was valued at USD 151.5 billion in 2025 and is projected to grow from USD 160.7 billion in 2026 to USD 249.3 billion by 2033, growing at a CAGR of 6.5% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 41.2% in 2025. The market comprises healthcare facilities that provide surgical procedures to patients who generally do not require hospital admission or an overnight stay.
In the U.S., CMS defines an ASC as a distinct facility operating primarily to provide surgical services to patients who do not require hospitalization, with expected stays generally limited to 24 hours. The market is supported by the increasing shift of surgical procedures from hospitals to outpatient settings, driven by demand for cost-efficient care, shorter recovery periods, improvements in minimally invasive techniques, advances in anesthesia, and growing patient preference for same-day treatment. ASCs increasingly accommodate procedures across specialties such as orthopedics, ophthalmology, gastroenterology, pain management, otolaryngology, gynecology, urology, and plastic surgery.
Global Ambulatory Surgery Centers Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of industry trends in each of the segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the ambulatory surgery centers market report based on specialty, ownership, type, services, and region:
- Specialty Outlook (Revenue, USD Billion, 2021 - 2033)
- Orthopedics
- Pain Management/Spinal Injections
- Gastroenterology
- Ophthalmology
- Plastic Surgery
- Otolaryngology
- Obstetrics/Gynecology
- Dental
- Podiatry
- Other Specialty
- Ownership Outlook (Revenue, USD Billion, 2021 - 2033)
- Physician Owned
- Hospital Owned
- Corporate Owned
- Type Outlook (Revenue, USD Billion, 2021 - 2033)
- Single-Specialty
- Multi-Specialty
- Services Outlook (Revenue, USD Billion, 2021 - 2033)
- Diagnosis
- Treatment
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Thailand
- Latin America
- MEA
- South Africa
- Saudi Arabia
- Kuwait
- UAE
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Specialty
- 1.2.2. Ownership
- 1.2.3. Type
- 1.2.4. Services
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Cost-effective alternative
- 3.2.1.2. Technological advancements and increasing demand for minimally invasive surgeries
- 3.2.1.3. Rising Demand for Efficient Same-Day Surgical Care
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Operational uncertainty
- 3.2.2.2. Regulatory concerns associated with outpatient care
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
Chapter 4. Specialty Business Analysis
- 4.1. Specialty Movement Analysis, 2025 & 2033
- 4.2. Specialty Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Specialty, 2021 to 2033 (USD Billion)
- 4.4. Orthopedics
- 4.4.1. Orthopedics market estimates and forecasts, 2021 - 2033 (USD Billion)
- 4.5. Pain Management/Spinal Injections
- 4.5.1. Pain Management/Spinal Injections market estimates and forecasts, 2021 - 2033 (USD Billion)
- 4.6. Gastroenterology
- 4.6.1. Gastroenterology market estimates and forecasts, 2021 - 2033 (USD Billion)
- 4.7. Ophthalmology
- 4.7.1. Ophthalmology market estimates and forecasts, 2021 - 2033 (USD Billion)
- 4.8. Plastic Surgery
- 4.8.1. Plastic Surgery market estimates and forecasts, 2021 - 2033 (USD Billion)
- 4.9. Otolaryngology
- 4.9.1. Otolaryngology market estimates and forecasts, 2021 - 2033 (USD Billion)
- 4.10. Obstetrics/Gynecology
- 4.10.1. Obstetrics/Gynecology market estimates and forecasts, 2021 - 2033 (USD Billion)
- 4.11. Dental
- 4.11.1. Dental market estimates and forecasts, 2021 - 2033 (USD Billion)
- 4.12. Podiatry
- 4.12.1. Podiatry market estimates and forecasts, 2021 - 2033 (USD Billion)
- 4.13. Other Specialty
- 4.13.1. Other Specialty market estimates and forecasts, 2021 - 2033 (USD Billion)
Chapter 5. Ownership Business Analysis
- 5.1. Ownership Movement Analysis, 2025 & 2033
- 5.2. Ownership Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analyses, by Ownership, 2021 to 2033 (USD Billion)
- 5.4. Physician Owned
- 5.4.1. Physician Owned market estimates and forecasts, 2021 - 2033 (USD Billion)
- 5.5. Hospital Owned
- 5.5.1. Hospital Owned market estimates and forecasts, 2021 - 2033 (USD Billion)
- 5.6. Corporate Owned
- 5.6.1. Corporate Owned market estimates and forecasts, 2021 - 2033 (USD Billion)
Chapter 6. Type Business Analysis
- 6.1. Type Movement Analysis, 2025 & 2033
- 6.2. Type Segment Dashboard
- 6.3. Market Size & Forecasts and Trend Analyses, by Type, 2021 to 2033 (USD Billion)
- 6.4. Single-Specialty
- 6.4.1. Single-specialty market estimates and forecasts, 2021 - 2033 (USD Billion)
- 6.5. Multi-Specialty
- 6.5.1. Multi-specialty market estimates and forecasts, 2021 - 2033 (USD Billion)
Chapter 7. Services Business Analysis
- 7.1. Services Movement Analysis, 2025 & 2033
- 7.2. Services Segment Dashboard
- 7.3. Market Size & Forecasts and Trend Analyses, by Services, 2021 to 2033 (USD Billion)
- 7.4. Diagnosis
- 7.4.1. Diagnosis market estimates and forecasts, 2021 - 2033 (USD Billion)
- 7.5. Treatment
- 7.5.1. Treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
Chapter 8. Regional Estimates & Trend Analysis by Specialty & Ownership
- 8.1. Regional Movement Analysis, 2025 & 2033
- 8.2. Regional Market Dashboard
- 8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033
- 8.4. North America
- 8.4.1. North America Ambulatory Surgery Centers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.4.2. U.S.
- 8.4.2.1. Key country dynamic
- 8.4.2.2. Regulatory framework
- 8.4.2.3. Competitive insights
- 8.4.2.4. U.S. ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.4.3. Canada
- 8.4.3.1. Key country dynamic
- 8.4.3.2. Regulatory framework
- 8.4.3.3. Competitive insights
- 8.4.3.4. Canada ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.4.4. Mexico
- 8.4.4.1. Key country dynamic
- 8.4.4.2. Regulatory framework
- 8.4.4.3. Competitive insights
- 8.4.4.4. Mexico ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.5. Europe
- 8.5.1. Europe Ambulatory Surgery Centers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.5.2. Germany
- 8.5.2.1. Key country dynamic
- 8.5.2.2. Regulatory framework
- 8.5.2.3. Competitive insights
- 8.5.2.4. Germany ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.5.3. UK
- 8.5.3.1. Key country dynamic
- 8.5.3.2. Regulatory framework
- 8.5.3.3. Competitive insights
- 8.5.3.4. UK ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.5.4. France
- 8.5.4.1. Key country dynamic
- 8.5.4.2. Regulatory framework
- 8.5.4.3. Competitive insights
- 8.5.4.4. France ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.5.5. Italy
- 8.5.5.1. Key country dynamic
- 8.5.5.2. Regulatory framework
- 8.5.5.3. Competitive insights
- 8.5.5.4. Italy ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.5.6. Spain
- 8.5.6.1. Key country dynamic
- 8.5.6.2. Regulatory framework
- 8.5.6.3. Competitive insights
- 8.5.6.4. Spain ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.5.7. Denmark
- 8.5.7.1. Key country dynamic
- 8.5.7.2. Regulatory framework
- 8.5.7.3. Competitive insights
- 8.5.7.4. Denmark ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.5.8. Sweden
- 8.5.8.1. Key country dynamic
- 8.5.8.2. Regulatory framework
- 8.5.8.3. Competitive insights
- 8.5.8.4. Sweden ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.5.9. Norway
- 8.5.9.1. Key country dynamic
- 8.5.9.2. Regulatory framework
- 8.5.9.3. Competitive insights
- 8.5.9.4. Norway ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.6. Asia Pacific
- 8.6.1. Asia Pacific Ambulatory Surgery Centers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.6.2. Japan
- 8.6.2.1. Key country dynamic
- 8.6.2.2. Regulatory framework
- 8.6.2.3. Competitive insights
- 8.6.2.4. Japan ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.6.3. China
- 8.6.3.1. Key country dynamic
- 8.6.3.2. Regulatory framework
- 8.6.3.3. Competitive insights
- 8.6.3.4. China ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.6.4. India
- 8.6.4.1. Key country dynamic
- 8.6.4.2. Regulatory framework
- 8.6.4.3. Competitive insights
- 8.6.4.4. India ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.6.5. South Korea
- 8.6.5.1. Key country dynamic
- 8.6.5.2. Regulatory framework
- 8.6.5.3. Competitive insights
- 8.6.5.4. South Korea ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.6.6. Australia
- 8.6.6.1. Key country dynamic
- 8.6.6.2. Regulatory framework
- 8.6.6.3. Competitive insights
- 8.6.6.4. Australia ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.6.7. Thailand
- 8.6.7.1. Key country dynamic
- 8.6.7.2. Regulatory framework
- 8.6.7.3. Competitive insights
- 8.6.7.4. Thailand ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.7. Latin America
- 8.7.1. Latin America Ambulatory Surgery Centers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.7.2. Brazil
- 8.7.2.1. Key country dynamic
- 8.7.2.2. Regulatory framework
- 8.7.2.3. Competitive insights
- 8.7.2.4. Brazil ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.7.3. Argentina
- 8.7.3.1. Key country dynamic
- 8.7.3.2. Regulatory framework
- 8.7.3.3. Competitive insights
- 8.7.3.4. Argentina ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.8. MEA
- 8.8.1. MEA Ambulatory Surgery Centers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.8.2. South Africa
- 8.8.2.1. Key country dynamic
- 8.8.2.2. Regulatory framework
- 8.8.2.3. Competitive insights
- 8.8.2.4. South Africa ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.8.3. Saudi Arabia
- 8.8.3.1. Key country dynamic
- 8.8.3.2. Regulatory framework
- 8.8.3.3. Competitive insights
- 8.8.3.4. Saudi Arabia ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.8.4. UAE
- 8.8.4.1. Key country dynamic
- 8.8.4.2. Regulatory framework
- 8.8.4.3. Competitive insights
- 8.8.4.4. UAE ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
- 8.8.5. Kuwait
- 8.8.5.1. Key country dynamic
- 8.8.5.2. Regulatory framework
- 8.8.5.3. Competitive insights
- 8.8.5.4. Kuwait ambulatory surgery centers market estimates and forecasts, 2021 - 2033 (USD Billion)
Chapter 9. Competitive Landscape
- 9.1. Participant Overview
- 9.2. Company Market Position Analysis, 2025
- 9.3. Company Categorization
- 9.4. Strategy Mapping
- 9.5. Company Profiles/Listing
- 9.5.1. CHSPSC, LLC.
- 9.5.1.1. Overview
- 9.5.1.2. Financial performance
- 9.5.1.3. Service benchmarking
- 9.5.1.4. Strategic initiatives
- 9.5.2. Edward-Elmhurst Health (Endeavor Health)
- 9.5.2.1. Overview
- 9.5.2.2. Financial performance
- 9.5.2.3. Service benchmarking
- 9.5.2.4. Strategic initiatives
- 9.5.3. MedNation AG, Bonn
- 9.5.3.1. Overview
- 9.5.3.2. Financial performance
- 9.5.3.3. Service benchmarking
- 9.5.3.4. Strategic initiatives
- 9.5.4. Envision
- 9.5.4.1. Overview
- 9.5.4.2. Financial performance
- 9.5.4.3. Service benchmarking
- 9.5.4.4. Strategic initiatives
- 9.5.5. Healthway Medical Group
- 9.5.5.1. Overview
- 9.5.5.2. Financial performance
- 9.5.5.3. Service benchmarking
- 9.5.5.4. Strategic initiatives
- 9.5.6. HCA Healthcare (C-HCA, Inc.)
- 9.5.6.1. Overview
- 9.5.6.2. Financial performance
- 9.5.6.3. Service benchmarking
- 9.5.6.4. Strategic initiatives
- 9.5.7. Pediatrix Medical Group
- 9.5.7.1. Overview
- 9.5.7.2. Financial performance
- 9.5.7.3. Service benchmarking
- 9.5.7.4. Strategic initiatives
- 9.5.8. Prospect Medical Holdings, Inc.
- 9.5.8.1. Overview
- 9.5.8.2. Financial performance
- 9.5.8.3. Service benchmarking
- 9.5.8.4. Strategic initiatives
- 9.5.9. SurgCenter
- 9.5.9.1. Overview
- 9.5.9.2. Financial performance
- 9.5.9.3. Service benchmarking
- 9.5.9.4. Strategic initiatives
- 9.5.10. Surgery Partners
- 9.5.10.1. Overview
- 9.5.10.2. Financial performance
- 9.5.10.3. Service benchmarking
- 9.5.10.4. Strategic initiatives
- 9.5.11. Tenet Health (TH Medical)
- 9.5.11.1. Overview
- 9.5.11.2. Financial performance
- 9.5.11.3. Service benchmarking
- 9.5.11.4. Strategic initiatives
- 9.5.12. UNITEDHEALTH GROUP
- 9.5.12.1. Overview
- 9.5.12.2. Financial performance
- 9.5.12.3. Service benchmarking
- 9.5.12.4. Strategic initiatives